|
1
|
- LRIG Mid Atlantic
- Bridgewater, NJ
- September 5
- Rodney Turner
|
|
2
|
|
|
3
|
- What was needed:
- Reliable, easy to fabricate valves and pumps
- Materials matched to task
- Scalable control scheme
- allow high level of integration
|
|
4
|
|
|
5
|
|
|
6
|
|
|
7
|
|
|
8
|
|
|
9
|
- Taken full advantage of rapid prototyping capability
- “Gandalf” feasibility test: over 100 designs to chips in 4 months
- FluidArchitect™ Software
- Eliminate prototype development as bottleneck
|
|
10
|
- Enable four key life science applications
- Tailor-made miniaturization for protein crystallization: enabled by
over 400 valves.
- High density PCR microprocessors for genotyping and gene expression:
1000s to 10,000s of nanoliter reaction volumes per chip.
- Unique PDMS gas permeability enables multiple live cell handling
capabilities: culture, perfuse, lyse and analyze in a single chip
- Miniaturized, heterogeneous protein assays in self-programmable
microprocessors: hundreds of valves and pumps per chip.
|
|
11
|
- BENEFITS
- Parallel capacity: 144 experiments in one microprocessor.
- Sample reduction: 2 orders of magnitude reduction in sample input
amount.
- Automation: Reduced sample handling and pipetting with improved
reproducibility.
- New crystallization conditions: Offers potential to discover
crystallization conditions for proteins that have not been crystallized
before.
|
|
12
|
- Ten 48-reagent microprocessors
- Ten microprocessor carriers
- Two microprocessor control boxes
- Two 8-channel manifolds
- Two 5-valve manifolds
- Detailed Protocol
- Control reagent set: Thaumatin crystallization
|
|
13
|
|
|
14
|
|
|
15
|
|
|
16
|
|
|
17
|
- A Bacterial RNase
- No crystals after a set of full commercial screens
- Crystals discovered in microprocessors
- Reproduced by sitting drop based on results from microprocessors
- Bacterial Primase
- Conventional screens gave only “promising” precipitate
- Microprocessors gave clear crystals in initial screens
- Conventional conditions found faster
- Topoisomerase ATPase
- New conditions discovered in microprocessors
- Reproduced in conventional techniques
- Bacterial Ribosome Proteins
- Also crystallized (data proprietary)
|
|
18
|
|
|
19
|
- Future work
- Co-crystallization
- Crystal recovery chip
- Observe compound-induced physical changes to crystals
|
|
20
|
- 10,000 quantitative PCR assays in a single microprocessor.
- Single loading step for 10,000 reactions.
- Decrease consumption of amplification reagents 5000-fold.
|
|
21
|
|
|
22
|
|
|
23
|
|
|
24
|
- Fluidigm PCR cocktail à
good signal strength in microfluidic format
|
|
25
|
- Stepwise reduction in the amount of DNA gives the expected PCR
signature:
|
|
26
|
|
|
27
|
- Harness the power of quantitative PCR
- 1 copy per 1,000 cells
- 5 orders-of-magnitude linear dynamic range
- Conduct 10,000 PCR reactions with a single loading step
- Reduce threshold cost for PCR analysis
- Reducing reaction volumes 5000x
|
|
28
|
- Key Features
- Miniaturization
- High Content Analysis
- Integration
|
|
29
|
|
|
30
|
- Focused Delivery
- Mixing is diffusion limited
- Precise control over reagent addition
|
|
31
|
- Trypan blue staining pre and post methanol perfusion
- 100 millisecond perfusion time!!!
|
|
32
|
- PBLs stained with Acridine Orange
|
|
33
|
|
|
34
|
|
|
35
|
|
|
36
|
|
|
37
|
- Enable immunoassay profiles in miniaturized format
- Automated approach lowers cost and improves data quality
- Integrate with miniaturized sample preparation capability
|
|
38
|
- Reagent and sample are delivered sequentially to a matrix of
intersecting channels bounded by isolation valves
- A unique assay occurs on the substrate at each channel intersection
- Fully automated delivery of samples, reagents, blocks and washes
- Processors conform to microscope slide dimensions
- Scan in standard array scanners
|
|
39
|
|
|
40
|
|
|
41
|
|
|
42
|
|
|
43
|
|
|
44
|
- Access existing programs
- Protein Crystallization chips ready to use
- Your genotyping content for Nucleic Acid Microprocessor
- Explore New Capabilities in Life Sciences
- Integration of Genome, Proteome and Live-cell studies on a single
platform
- Rapid Design Prototyping
|
|
45
|
- www.fluidigm.com
- Rodney Turner
- VP Business Development
- rodney.turner@fluidigm.com
- Kristin Spataro
- Manager, Business Development
- kristin.spataro@fluidigm.com
|